Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U E Heidland

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Circulation|September 26, 2001
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruptionU E Heidland, B E Strauer
Deutsche Medizinische Wochenschrift (1946)|January 17, 1997
[Ischemic preconditioning: the potentials and limits of the analysis and use of endogenous myocardial protection in man]U E Heidland, M P Heintzen, B E Strauer
Zeitschrift Fur Kardiologie|November 1, 1995
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences]B E Strauer, U E Heidland, M P Heintzen, et al.
American Heart Journal|October 31, 2000
Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosineU E Heidland, M P Heintzen, B Schwartzkopff, et al.
Journal of the American College of Cardiology|November 1, 1996
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performanceB E Strauer, U E Heidland, M P Heintzen, et al.
Zeitschrift Fur Kardiologie|October 29, 1998
[Is there a prognostic indication for PTCA?]M P Heintzen, C J Michel, U E Heidland, et al.
Deutsche Medizinische Wochenschrift (1946)|January 12, 2001
[Operation or angioplasty in coronary heart disease--a summary of prospective randomized studies]U E Heidland, C J Michel, M P Heintzen, et al.
Coronary Artery Disease|December 7, 2000
Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioningU E Heidland, M P Heintzen, C J Michel, et al.
Heart (British Cardiac Society)|February 17, 2001
Risk factors for the development of restenosis following stent implantation of venous bypass graftsU E Heidland, M P Heintzen, C J Michel, et al.
American Heart Journal|May 29, 2000
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trialU E Heidland, M P Heintzen, C J Michel, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Circulation|September 26, 2001
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruptionU E Heidland, B E Strauer
Deutsche Medizinische Wochenschrift (1946)|January 17, 1997
[Ischemic preconditioning: the potentials and limits of the analysis and use of endogenous myocardial protection in man]U E Heidland, M P Heintzen, B E Strauer
Zeitschrift Fur Kardiologie|November 1, 1995
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences]B E Strauer, U E Heidland, M P Heintzen, et al.
American Heart Journal|October 31, 2000
Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosineU E Heidland, M P Heintzen, B Schwartzkopff, et al.
Journal of the American College of Cardiology|November 1, 1996
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performanceB E Strauer, U E Heidland, M P Heintzen, et al.
Zeitschrift Fur Kardiologie|October 29, 1998
[Is there a prognostic indication for PTCA?]M P Heintzen, C J Michel, U E Heidland, et al.
Deutsche Medizinische Wochenschrift (1946)|January 12, 2001
[Operation or angioplasty in coronary heart disease--a summary of prospective randomized studies]U E Heidland, C J Michel, M P Heintzen, et al.
Coronary Artery Disease|December 7, 2000
Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioningU E Heidland, M P Heintzen, C J Michel, et al.
Heart (British Cardiac Society)|February 17, 2001
Risk factors for the development of restenosis following stent implantation of venous bypass graftsU E Heidland, M P Heintzen, C J Michel, et al.
American Heart Journal|May 29, 2000
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trialU E Heidland, M P Heintzen, C J Michel, et al.
Pageof 2